Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK-Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study - Solomon, BJ; Bauer, TM; Ignatius Ou, S-H (J Clin Oncol, 2022)